UCB Pharmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-07-08
Share capital
30,294,300.00 PLN
Registered address
ul. Leona Kruczkowskiego 8, 00-380 Warszawa, Poland
Electronic delivery address
AE:PL-74117-88528-IHVBT-21

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 36 days early. All were audited by a statutory auditor.

  • 2025filed
  • 202425/06/2025
  • 202317/06/2024
  • 202212/07/2023
  • 202123/06/2022
  • 202002/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 47.44mMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 1.38mMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 44.72mMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 26.16mMedianUSD 608.93kAverageUSD 11.85m

Trademarks

UCB Pharma holds 2 active trademarks registered with the Polish Patent Office. 26 marks have expired or were not registered. The first mark was filed in 1998.

MarkNumberClassesStatusProtected until
IPRES(word)Z.2570545Protected Nov 4, 2032
PROSTATIC(word)Z.2003745Protected Apr 12, 2029
eduneuroZ.3133225, 9, 10, 16, 35, 41, 42, 44Expired –
Cargul(word)Z.3119475Expired –
PROSTAMNIC(word)Z.3023155Expired –
MarkProtected until
IPRES(word)Nov 4, 2032
PROSTATIC(word)Apr 12, 2029
eduneuro–
Cargul(word)–
PROSTAMNIC(word)–

Authorized Representatives

Florentina Adriana Păncescu – Management Board Member
Laura Byram – President of the Management Board
Szymon Byzia – Attorney-in-fact
Dimitrios Koulaxidis – Management Board Member
Tomasz Stasiewski – Management Board Member

Manner of representation

In the case of a multi-member management board, the President of the Management Board is authorised to represent the company independently, two members of the management board jointly, a member of the management board jointly with a commercial proxy, or two commercial proxies.

Ownership

OwnerSharesShare valueStake
Ucb Farchim S.A.
66,487$1,795,975.1521.947%
Ucb S.A.
236,456$6,387,250.1478.053%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2003-12-31.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Orkla CareS.A.
Synkmedsp. z o.o.
Intimexsp. z o.o. + limited partnership
Medif sp. z o.o.sp. k.
PromedS.A.
AO East Europesp. z o.o.
MassmedicaS.A.
SPA Landsp. z o.o.
Hair Partnerssp. z o.o.
Balmed Polandsp. z o.o.

Change history

DateEvent
2019-08-02Address change
2018-03-23Address change
2005-12-08Address change
2004-07-15Share capital increase
2002-07-08Entered in the register

FAQ

Last updated: 2026-04-05